β Home
βΉοΈ Info
π§Ύ At a Glance π Core Facts ποΈ Products/Services β Ratings π§βπΌ Executives π¬ My Commentsπ‘ Analytics
π Insights π’ Company Q&A (464) π οΈ Industry Q&A (98) π Competitors π Price Low π Price Swings β‘ SWOT ποΈ PEST π Porter's Five Forces β¨ Score Positive β οΈ Risk Assessment π§© Segmentation π Ά Google Linksπ Ratios
π° Margins π Financial Ratios π± Growth π Enterprise Value π Key Metrics π΅ Dividendsπ§ Tools
β Due DiligenceποΈ Products/Services
AbbVie is a pharmaceutical company that focuses on developing and commercializing medicines and therapies for various medical conditions. Some of the main products and services offered by AbbVie are:
1. Humira: Humira is the top-selling drug for AbbVie and is used to treat several chronic inflammatory conditions such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and Crohn's disease.
2. Imbruvica: Imbruvica is a targeted therapy used to treat certain types of blood cancers, including chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL).
3. Skyrizi: Skyrizi is a medication used to treat adults with moderate to severe plaque psoriasis, a chronic autoimmune skin condition.
4. Venclexta: Venclexta is a prescription medicine used to treat chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).
5. Mavyret: Mavyret is an all-oral, short-course treatment option for patients with chronic hepatitis C virus (HCV) infection.
6. Duopa: Duopa is a levodopa-carbidopa intestinal gel used to treat motor fluctuations in patients with advanced Parkinson's disease.
7. Synthroid: Synthroid is a medication used to treat hypothyroidism, a condition where the thyroid gland does not produce enough thyroid hormone.
8. Lupron: Lupron is a hormone therapy used to treat endometriosis, uterine fibroids, and certain types of prostate cancer.
9. AndroGel: AndroGel is a prescription testosterone replacement therapy used to treat adult males with low or no testosterone due to certain medical conditions.
10. Botox: AbbVie acquired the rights to develop and commercialize Botox, a drug used for the treatment of chronic migraine and cervical dystonia.
See Company Q&A
1. Humira: Humira is the top-selling drug for AbbVie and is used to treat several chronic inflammatory conditions such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and Crohn's disease.
2. Imbruvica: Imbruvica is a targeted therapy used to treat certain types of blood cancers, including chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL).
3. Skyrizi: Skyrizi is a medication used to treat adults with moderate to severe plaque psoriasis, a chronic autoimmune skin condition.
4. Venclexta: Venclexta is a prescription medicine used to treat chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).
5. Mavyret: Mavyret is an all-oral, short-course treatment option for patients with chronic hepatitis C virus (HCV) infection.
6. Duopa: Duopa is a levodopa-carbidopa intestinal gel used to treat motor fluctuations in patients with advanced Parkinson's disease.
7. Synthroid: Synthroid is a medication used to treat hypothyroidism, a condition where the thyroid gland does not produce enough thyroid hormone.
8. Lupron: Lupron is a hormone therapy used to treat endometriosis, uterine fibroids, and certain types of prostate cancer.
9. AndroGel: AndroGel is a prescription testosterone replacement therapy used to treat adult males with low or no testosterone due to certain medical conditions.
10. Botox: AbbVie acquired the rights to develop and commercialize Botox, a drug used for the treatment of chronic migraine and cervical dystonia.

π Get full analytics about AbbVie
Sign up for free or log inπ Donβt miss "The Checklist Value Investor β A Smarter Way to Pick Stocks" β free!